Welcome to Francis Academic Press
Login | Register

Frontiers in Medical Science Research, 2025, 7(3); doi: 10.25236/FMSR.2025.070311.

Research Progress on the Relationship between Red Blood Cell Lifespan and Rheumatic Immune System Diseases

Author(s)

Wu Na1, Wang Xiaojun2

Corresponding Author:
Wang Xiaojun
Affiliation(s)

1Shaanxi University of Chinese Medicine, Xianyang, China

2The Seventh Clinical School of Shaanxi University of Chinese Medicine, Ankang, China

Abstract

The lifespan of red blood cells (RBCs) is critical for maintaining normal blood circulation and oxygen transport. Rheumatic immune system diseases, however, can disrupt blood system functions through various immune mechanisms, potentially altering RBC lifespan. In recent years, growing evidence suggests that conditions such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) accelerate RBC destruction or modify their lifecycle via autoimmune responses and chronic inflammation. This review examines the relationship between RBC lifespan and rheumatic immune diseases, exploring the mechanisms by which these diseases affect RBC lifespan and their clinical implications. It also summarizes current research findings and technological advancements. Furthermore, the article discusses the potential of RBC lifespan as a biomarker for clinical diagnosis and disease monitoring, aiming to provide theoretical support for early diagnosis and personalized treatment of rheumatic immune diseases.

Keywords

Red Blood Cell Lifespan, Rheumatic Immune System Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Cite This Paper

Wu Na, Wang Xiaojun. Research Progress on the Relationship between Red Blood Cell Lifespan and Rheumatic Immune System Diseases. Frontiers in Medical Science Research (2025), Vol. 7, Issue 3: 80-85. https://doi.org/10.25236/FMSR.2025.070311.

References

[1] Rybtsova, Natalia, Tatiana N. Berezina, and Stanislav Rybtsov. “Molecular markers of blood cell populations can help estimate aging of the immune system.” International Journal of Molecular Sciences 24.6 (2023): 5708.

[2] Da Silva, Rose Mary Ferreira L., and Lucas Espindula Borges. “Neutrophil-lymphocyte ratio and red blood cell distribution width in patients with atrial fibrillation and rheumatic valve disease.” Current Vascular Pharmacology 21.6 (2023): 367-377.

[3] Guder, Christian, et al. “Osteoimmunology: a current update of the interplay between bone and the immune system.” Frontiers in Immunology 11 (2020): 58.

[4] Qu, Jiling, et al. “Correlation analysis of hemoglobin-to-red blood cell distribution width ratio and frailty in elderly patients with coronary heart disease.” Frontiers in cardiovascular medicine 8 (2021): 728800.

[5] Bianchi, Marzia, et al. “Preclinical and clinical developments in enzyme-loaded red blood cells: An update.” Expert Opinion on Drug Delivery 20.7 (2023): 921-935.

[6] Ren, Yijun, Chengkai Yan, and Huan Yang. “Erythrocytes: Member of the immune system that should not be ignored.” Critical Reviews in Oncology/Hematology 187 (2023): 104039.

[7] Cabling, Marven G., et al. “Cardiovascular disease and bone health in aging female rheumatic disease populations: A review.” Women’s Health 19 (2023): 17455057231155286.

[8] Luo, Ting-Ting, et al. “The involvement of glucose and lipid metabolism alteration in rheumatoid arthritis and its clinical implication.” Journal of Inflammation Research (2023): 1837-1852.

[9] Jang, Sunhee, Eui-Jong Kwon, and Jennifer Jooha Lee. “Rheumatoid arthritis: pathogenic roles of diverse immune cells.” International journal of molecular sciences 23.2 (2022): 905.

[10] Dooley, Leanne M., et al. “Rheumatic heart disease: a review of the current status of global research activity.” Autoimmunity reviews 20.2 (2021): 102740.